Regulation of Drug Prescribing Information in Latin America and the Caribbean
Open Access
- 5 April 2022
- journal article
- review article
- Published by Springer Nature in Therapeutic Innovation & Regulatory Science
- Vol. 56 (4) , 536-551
Abstract
Objective: To describe the status of drug regulations in Latin America and the Caribbean, in force as of May 2021, and assess through a comparative exercise the differences between the countries under scope on prescribing information of drugs for human use. Materials and Methods: A narrative review allowed the identification of the regulations concerning the prescribing information of drugs in 25 countries in Latin America and the Caribbean for the registration of prescription medications. On this basis, terms and concepts regarding this topic, the general provisions by the regulatory authorities for these products, applications for health registration and further amendments were identified for each country. Results: The Latin American and the Caribbean countries included, manage and regulate drug prescribing information differently in terms of concepts, information publishing, structure for product information, among other criteria. Few health authorities publish product information on their website. Additionally, the patient information leaflet is not requested for prescription drugs in most of the studied countries. There is no standardized structure for drug product information within the region. Conclusions: A poor level of harmonization among the regulations from these countries regarding the content and management (e.g. if physical package insert is required or not, if it is subject to notification or approval) of the prescribing information of human use drugs became evident. Also, there is a visible lack of standardization of concepts for referring to a specific document (e.g., package insert for healthcare professionals, patient information leaflet and technical information for the drug product) and in the content itself.Keywords
This publication has 24 references indexed in Scilit:
- Readability Assessment of Package Inserts of Biological Medicinal Products from the European Medicines Agency WebsiteDrug Safety, 2014
- Self-rated health in multimorbid older general practice patients: a cross-sectional study in GermanyBMC Family Practice, 2014
- Community Pharmacists’ Perception of the Relevance of Drug Package Insert as Source of Drug Information in Southwestern NigeriaTropical Journal of Pharmaceutical Research, 2013
- Caring for visually impaired patientsJournal of the American Pharmacists Association, 2013
- Acesso a informações de saúde na internet: uma questão de saúde pública?Revista da Associação Médica Brasileira, 2012
- Revisión sobre el uso de medicamentos en condiciones no incluidas en su ficha técnicaFarmacia Hospitalaria, 2011
- Health Literacy: What Is It?Journal of Health Communication, 2010
- From prescription-only to over-the-counter medicines ('PoM to P'): time for an intermediate categoryBritish Medical Bulletin, 2009
- Evolução histórica das bulas de medicamentos no BrasilCadernos de Saude Publica, 2008
- Reducing disparities in the access and use of Internet health information. A discussion paperInternational Journal of Nursing Studies, 2007